1. Home
  2. SGI vs GMAB Comparison

SGI vs GMAB Comparison

Compare SGI & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGI

Somnigroup International Inc.

HOLD

Current Price

$86.06

Market Cap

20.2B

ML Signal

HOLD

Logo Genmab A/S ADS

GMAB

Genmab A/S ADS

HOLD

Current Price

$28.23

Market Cap

19.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGI
GMAB
Founded
1846
1999
Country
United States
Denmark
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2B
19.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SGI
GMAB
Price
$86.06
$28.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$94.50
$40.93
AVG Volume (30 Days)
2.1M
1.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.03
$17.80
Revenue Next Year
$5.10
$14.86
P/E Ratio
$48.98
$1.90
Revenue Growth
N/A
N/A
52 Week Low
$53.10
$17.24
52 Week High
$98.56
$35.43

Technical Indicators

Market Signals
Indicator
SGI
GMAB
Relative Strength Index (RSI) 41.80 35.31
Support Level $82.56 $28.17
Resistance Level $87.44 $33.98
Average True Range (ATR) 3.71 0.78
MACD -0.60 -0.08
Stochastic Oscillator 17.36 24.11

Price Performance

Historical Comparison
SGI
GMAB

About SGI Somnigroup International Inc.

Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses, Tempur Sealy, Mattress Firm and Dreams. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Share on Social Networks: